Clinical Trials Logo
  1. Home
  2. Candidiasis, Oral
  3. NCT02184351

Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis

Candidiasis, Oral Clinical Trial

Official title:
A Prospective Randomized, Blinded Parallel Group Study of Clotrimazole Troches vs. Mycelex® Troches (10 mg Troche Five Times a Day for 14 Days) in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis

Clinical Trial Summary

The objectives of this study are to compare the efficacy and safety of Roxane's clotrimazole troches vs. Mycelex troches in HIV positive patients with oropharyngeal candidiasis, where this condition has been diagnosed by clinical examination and confirmed by fungal culture.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02184351
Study type Interventional
Source Boehringer Ingelheim
Contact
Status Completed
Phase Phase 3
Start date May 2001
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03250923 - CelAgace™ OraRinse Solution for Treatment of Candidiasis Phase 1/Phase 2
Completed NCT00004781 - Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups N/A
Completed NCT03894839 - Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Species N/A
Completed NCT00128323 - A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis Phase 3
Recruiting NCT04410250 - Effect of Oral Hygienization in Newborn on Candida Spp Colonization N/A
Recruiting NCT03873753 - Relationship Between Oral Hygiene in Newborns and Candida Spp. N/A
Completed NCT00665639 - Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis Phase 3
Completed NCT02818803 - Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic Phase 3
Active, not recruiting NCT06120816 - Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis Phase 1
Completed NCT00235053 - Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID Phase 4
Completed NCT00666185 - Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis Phase 3
Completed NCT00002446 - Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients Phase 3
Completed NCT00001448 - The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection N/A
Completed NCT00612963 - Novel Rinse to Treat in Oral Candidiasis in Cancer Patients N/A
Completed NCT00001812 - A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 Phase 3
Terminated NCT00005920 - Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole Phase 2
Completed NCT00002293 - A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes N/A
Completed NCT00002133 - An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects. N/A
Completed NCT00002112 - Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome N/A
Completed NCT00000951 - A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush Phase 4